1. Home
  2. EFSI vs TNXP Comparison

EFSI vs TNXP Comparison

Compare EFSI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$40.55

Market Cap

225.9M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.61

Market Cap

192.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSI
TNXP
Founded
1881
2007
Country
United States
United States
Employees
253
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.9M
192.9M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
EFSI
TNXP
Price
$40.55
$12.61
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$41.50
N/A
AVG Volume (30 Days)
78.5K
531.0K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$31.93
$558.11
Revenue Next Year
$4.38
$38.29
P/E Ratio
$24.38
N/A
Revenue Growth
N/A
29.85
52 Week Low
$31.44
$10.03
52 Week High
$44.00
$69.65

Technical Indicators

Market Signals
Indicator
EFSI
TNXP
Relative Strength Index (RSI) 47.93 52.03
Support Level $37.95 $11.98
Resistance Level $41.06 $13.17
Average True Range (ATR) 1.39 0.85
MACD -0.30 0.10
Stochastic Oscillator 25.92 54.16

Price Performance

Historical Comparison
EFSI
TNXP

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: